Dr. Ali Farooq Iqtidar, MD

Dr. Iqtidar practices at Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana.

Dr. Iqtidar's NPI, 1780781088, was assigned on September 20, 2006. Dr. Iqtidar graduated from Aga Khan Medical College in 2002. Dr. Iqtidar's Indiana license number on file is 01068807A.

Dr. Iqtidar's primary practice is Ascension St Vincent Hospital- Indianapolis, at 2001 W 86th St, Indianapolis, IN 46260 in Marion County. The practice phone is (317) 338-2172.

Dr. Iqtidar's primary practice is Ascension St Vincent Hospital- Indianapolis in Indianapolis, Indiana. Dr. Iqtidar is also affiliated with IU Health Methodist Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Iqtidar to 4 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Iqtidar practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Iqtidar's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Iqtidar is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Iqtidar's licenses on file in 2 states: Indiana and Connecticut.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Iqtidar treats.

CMS data shows 2,049 Medicare services from Dr. Iqtidar across 36 procedure codes in 2024, for 825 Medicare patients. Medicare paid $123,565 for them.

CMS counts 825 Medicare patients who saw Dr. Iqtidar in 2024. The largest group is 65 to 74, with 339 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Iqtidar's median patient age at 66, with 47% women.

In 2024, Dr. Iqtidar wrote 4,547 Medicare Part D claims for 598 patients. 86% of them were for generic drugs. CMS names the drug for 4,379 of them, across 52 drugs with 11 or more claims each, at $799,868 in total drug cost. In 2023, CMS named 3,861 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Iqtidar for performance year 2024, reported individually. Dr. Iqtidar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 41 procedures of coronary angioplasty and stenting by Dr. Iqtidar, more than 77% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Iqtidar, published from 2011 to 2024. The most frequent topics are Angioplasty, Balloon, Coronary and Cardiac Catheterization. Dr. Iqtidar's most frequent co-authors are Jeffrey A. Breall, MD, Kyle Andrew Frick, MD and Ziad Adnan Jaradat, MD.

CMS Open Payments shows 233 general payments to Dr. Iqtidar from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. Abbott Laboratories paid the most, $21,356.

Dmand AI lists 2 awards for Dr. Iqtidar.

Dr. Iqtidar graduated from Aga Khan Medical College in 2002. Dr. Iqtidar is a member of ACC.

Dr. Iqtidar is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.